Zevra Therapeutics, Inc. (ZVRA)
11.65
-0.22
(-1.85%)
USD |
NASDAQ |
Aug 24, 16:00
11.66
+0.01
(+0.09%)
After-Hours: 20:00
Zevra Therapeutics Max Drawdown (5Y) : 96.86% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 96.86% |
| June 30, 2026 | 96.86% |
| May 31, 2026 | 96.86% |
| April 30, 2026 | 96.86% |
| March 31, 2026 | 97.10% |
| February 28, 2026 | 97.10% |
| January 31, 2026 | 97.92% |
| December 31, 2025 | 98.13% |
| November 30, 2025 | 98.13% |
| October 31, 2025 | 98.13% |
| September 30, 2025 | 98.13% |
| August 31, 2025 | 98.13% |
| July 31, 2025 | 98.26% |
| June 30, 2025 | 98.93% |
| May 31, 2025 | 99.26% |
| April 30, 2025 | 99.27% |
| March 31, 2025 | 99.27% |
| February 28, 2025 | 99.27% |
| January 31, 2025 | 99.27% |
| December 31, 2024 | 99.27% |
| November 30, 2024 | 99.27% |
| October 31, 2024 | 99.27% |
| September 30, 2024 | 99.27% |
| August 31, 2024 | 99.27% |
| July 31, 2024 | 99.27% |
| Date | Value |
|---|---|
| June 30, 2024 | 99.27% |
| May 31, 2024 | 99.27% |
| April 30, 2024 | 99.27% |
| March 31, 2024 | 99.27% |
| February 29, 2024 | 99.27% |
| January 31, 2024 | 99.27% |
| December 31, 2023 | 99.27% |
| November 30, 2023 | 99.27% |
| October 31, 2023 | 99.27% |
| September 30, 2023 | 99.27% |
| August 31, 2023 | 99.27% |
| July 31, 2023 | 99.27% |
| June 30, 2023 | 99.27% |
| May 31, 2023 | 99.27% |
| April 30, 2023 | 99.27% |
| March 31, 2023 | 99.27% |
| February 28, 2023 | 99.27% |
| January 31, 2023 | 99.27% |
| December 31, 2022 | 99.27% |
| November 30, 2022 | 99.27% |
| October 31, 2022 | 99.27% |
| September 30, 2022 | 99.27% |
| August 31, 2022 | 99.27% |
| July 31, 2022 | 99.27% |
| June 30, 2022 | 99.27% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Innoviva, Inc. | 47.01% |
| Collegium Pharmaceutical, Inc. | 51.32% |
| Johnson & Johnson | 18.44% |
| Ligand Pharmaceuticals, Inc. | 72.85% |
| Harrow, Inc. | 71.15% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -13.17 |
| Beta (5Y) | 0.9058 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 55.66% |
| Historical Sharpe Ratio (5Y) | -0.0868 |
| Historical Sortino (5Y) | -0.1768 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.54% |